Used as a key intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules. Its boronic acid group enables Suzuki-Miyaura cross-coupling reactions, allowing efficient formation of carbon-carbon bonds in heterocyclic systems. The presence of fluorine and cyano groups enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in the preparation of compounds targeting cancer, inflammation, and central nervous system disorders. Its structural features make it valuable in medicinal chemistry for optimizing potency and pharmacokinetic properties.